Staar Surgical reported a net income of $0.6 million, or $0.01 per share, in the first quarter of 2018 compared with a net loss of $2.2 million, or $0.05 per share, in the first quarter of 2017, according to a press release.
Net sales increased 33% to $27.1 million from $20.4 million. This was attributed to injector part sales and ICL revenue and unit growth.
Operating expenses increased from $16.7 million in 2017’s first quarter to $18.6 million this year. Marketing and selling expenses also increased, from $6.5 million to (Read more...)